AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It...

Published on 13 Nov 2024 on Benzinga · via AOL

AstraZeneca Plc (NASDAQ:AZN) reported third-quarter sales of $13.57 billion, up 18% year over year...

Read the rest of the article

Start tracking your investments with Statfolio

The stock traded at an average price of $31.58 during the quarter. Portfolio Overview As of...

GuruFocus.com · via Yahoo Finance 15 Nov 2024

Down” alerts for three incredible companies, and there may not be another chance like this anytim...

The Motley Fool · via AOL 14 Nov 2024

The stock's average trading price was $1,112.86 during the quarter, with a -30.47% return over th...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

AstraZeneca Plc is increasingly looking to the United States for growth as its once fast-expandin...

The Boston Globe 13 Nov 2024

Firstly, all of the materials presented today are available on our AstraZeneca Investor Relations...

The Motley Fool · via AOL 13 Nov 2024

AstraZeneca Plc (NASDAQ:AZN) reported third-quarter sales of $13.57 billion, up 18% year over yea...

Benzinga · via AOL 13 Nov 2024

AstraZeneca Plc (NASDAQ:AZN) reported third-quarter sales of $13.57 billion, up 18% year over yea...

Benzinga · via Yahoo Finance 12 Nov 2024

AstraZeneca plc AZN is set to report its third-quarter 2024 earnings Tuesday morning, and the com...

Benzinga 12 Nov 2024

Based on the consensus recommendation from 7 brokerage firms, AstraZeneca PLC's (OSTO:AZN) averag...

GuruFocus.com · via Yahoo Finance 11 Nov 2024

We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are go...

Insider Monkey · via Yahoo Finance 10 Nov 2024